Huashan Hospital: Hepatitis B, Chronic trials
The registry lists 10 Hepatitis B, Chronic studies with Huashan Hospital as lead sponsor. 5 are open to participants now and 0 have results posted.
Phase 4 3No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Sequential PEG-IFN for HBV After Ending RNA-targeted RegimensRecruitingNCT06923280Not applicable
- Pegylated Interferon Alfa-2b in Reducing Relapse Rates After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative CHB Patients with Low Level HBsAgNot yet recruitingNCT06900166Phase 4
- Improved Sensitivity Detection of Serum HBsAg and HBsAg ReversionRecruitingNCT06550622
- Real-world Study Optimizing Nucleotide-analoguesRecruitingNCT05937178
- Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis BRecruitingNCT04896255
- Functional Cure Rate of Peg-IFNα-2b Combined With TAF in HBeAg Negative CHB PatientsCompletedNCT05490836Not applicable
- Efficacy and Safety of TAF for 48 Weeks in HBeAg Positive CHB PatientsStatus unknownNCT04864366
- The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by ResectionStatus unknownNCT03253250Phase 4
- Pegylated Interferon(Peg-IFN) in Reducing Relapse Rate in Patients After Discontinuation of NUC TherapyCompletedNCT02594293Phase 4
- Switch or Sequential Combination Therapy of Peginterferon in Hepatitis B Patients With Longterm Entecavir TherapyStatus unknownNCT02589652